Thorax · 2016 · 316 citations · 35 references
Health ProfessionsHealth SciencesHealth AssessmentPulmonary RehabilitationRehabilitationChronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease RehabilitationHealth Status MeasurementHealth-related Quality Of Life MeasurementPatient-reported Outcome MeasuresRespiratory RehabilitationDisease Severity EstimationDisease Severity IndexDisease-specific Health StatusDyspnea Severity ScalesEuroqol Five DimensionsHealth Assessment QuestionnairesHealth Status IndicesHealth Status Instruments
BACKGROUND: The EQ-5D, a generic health status questionnaire that is widely used in health economic evaluation, was recently expanded to the EQ-5D-5L to address criticisms of unresponsiveness and ceiling effect. AIMS: To describe the validity, responsiveness and minimum important difference of the EQ-5D-5L in COPD. METHODS: Study 1: The validity of the EQ-5D-5L utility index and visual analogue scale (EQ-VAS) was compared with four established disease-specific health status questionnaires and other measures of disease severity in 616 stable outpatients with COPD. Study 2: The EQ-5D-5L utility index and EQ-VAS were measured in 324 patients with COPD before and after 8 weeks of pulmonary rehabilitation. Distribution and anchor-based approaches were used to estimate the minimum important difference. RESULTS: There were moderate-to-strong correlations between utility index and EQ-VAS with disease-specific questionnaires (Pearson's r=0.47-0.72). A ceiling effect was seen in 7% and 2.6% of utility index and EQ-VAS. Utility index decreased (worsening health status) with indices of worsening disease severity. With rehabilitation, mean (95% CI) changes in utility index and EQ-VAS were 0.065 (0.047 to 0.083) and 8.6 (6.5 to 10.7), respectively, with standardised response means of 0.39 and 0.44. The mean (range) anchor estimates of the minimum important difference for utility index and EQ-VAS were 0.051 (0.037 to 0.063) and 6.9 (6.5 to 8.0), respectively. CONCLUSIONS: The EQ-5D-5L is a valid and responsive measure of health status in COPD and may provide useful additional cost-effectiveness data in clinical trials.
35
EuroQol - a new facility for the measurement of health-related quality of life
Health Policy · 1990 · 15.8K citations
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Michael Herdman, Claire Gudex, Andrew Lloyd et al. · Quality of Life Research · 2011 · 10K citations · Full text
Lung volumes and forced ventilatory flows
PH Quanjer, G J Tammeling, J. E. Cotes et al. · European Respiratory Journal · 1993 · 5.3K citations · Full text
Quanjer Ph, Tammeling Gj, Cotes Je et al. · PubMed · 1993 · 3.8K citations
Health Professions, Clinical Sciences, Internal Medicine +17
The St George's Respiratory Questionnaire
Paul Jones, Frances Quirk, Chloë M. Baveystock · Respiratory Medicine · 1991 · 2.7K citations · Full text